Kata Bölcskei Selected Research

Hypoglycemic Agents (Hypoglycemics)

1/2018

Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kata Bölcskei Research Topics

Disease

25	Hyperalgesia 01/2023 - 05/2003
16	Pain (Aches) 01/2023 - 09/2004
11	Inflammation (Inflammations) 01/2023 - 02/2016
8	Arthritis (Polyarthritis) 02/2021 - 07/2005
6	Migraine Disorders (Migraine) 12/2023 - 01/2016
5	Neuroinflammatory Diseases 01/2023 - 04/2020
4	Rheumatoid Arthritis 02/2021 - 10/2014
4	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 12/2016
4	Edema (Dropsy) 01/2019 - 10/2014
3	Neuralgia (Stump Neuralgia) 03/2021 - 09/2003
2	Necrosis 01/2023 - 12/2017
2	Surgical Wound 10/2022 - 03/2009
2	Headache (Headaches) 09/2022 - 10/2021
2	Hypotension (Low Blood Pressure) 01/2022 - 07/2005
2	Facial Pain (Myofacial Pain) 04/2020 - 01/2016
2	Chronic Pain 10/2017 - 01/2017
1	Pathologic Processes 01/2023
1	Stomach Ulcer (Gastric Ulcer) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2021
1	Movement Disorders (Movement Disorder) 01/2019
1	Mononeuropathies (Mononeuritis Multiplex) 01/2018
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 12/2017
1	Infections 12/2017
1	Mycoplasma Infections 12/2017

Drug/Important Bio-Agent (IBA)

8	Capsaicin (Zostrix)FDA Link 01/2023 - 07/2005
6	resiniferatoxinIBA 02/2021 - 05/2003
6	Formaldehyde (Formol)FDA Link 01/2018 - 09/2004
6	TRPV1 receptorIBA 10/2017 - 07/2005
5	AnkyrinsIBA 12/2019 - 01/2018
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2016 - 09/2004
4	CarrageenanIBA 01/2023 - 10/2005
4	Analgesics (Analgesic Drugs)IBA 01/2018 - 05/2003
3	CytokinesIBA 01/2023 - 10/2021
3	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 02/2022 - 01/2009
3	NeuropeptidesIBA 02/2021 - 09/2003
3	Freund's AdjuvantIBA 04/2020 - 07/2005
3	CuprizoneIBA 12/2019 - 12/2016
3	Peroxidase (Myeloperoxidase)IBA 01/2019 - 10/2014
3	Opioid Analgesics (Opioids)IBA 01/2018 - 06/2007
3	Diclofenac (SR 38)FDA LinkGeneric 03/2009 - 05/2003
3	Morphine (MS Contin)FDA LinkGeneric 03/2009 - 05/2003
2	Peptides (Polypeptides)IBA 12/2023 - 01/2023
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2023 - 01/2018
2	hemokinin-1IBA 01/2023 - 04/2020
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2015
2	incobotulinumtoxinA FDA Link 01/2019 - 01/2017
2	Lipoxygenase (Lipoxygenase-1)IBA 02/2010 - 07/2005
2	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 03/2009 - 06/2007
2	Streptozocin (Streptozotocin)FDA Link 10/2005 - 09/2004
1	Calcitonin Gene-Related PeptideIBA 12/2023
1	Isoleucine (L-Isoleucine)FDA Link 01/2023
1	Proline (L-Proline)FDA Link 01/2023
1	Cocaine (Cocaine HCl)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	cocaine- and amphetamine-regulated transcript protein (55-102)IBA 01/2023
1	Toll-Like Receptor 4IBA 01/2023
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2023
1	anthrax toxin receptorsIBA 01/2023
1	TachykininsIBA 01/2023
1	Tachykinin Receptors (Tachykinin Receptor)IBA 01/2023
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023
1	SiliconesIBA 10/2022
1	PolymersIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 09/2022
1	Messenger RNA (mRNA)IBA 09/2022
1	human MIRN3202 microRNAIBA 09/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 09/2022
1	MicroRNAs (MicroRNA)IBA 09/2022
1	Neuroprotective AgentsIBA 02/2022
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 02/2022
1	9-phenanthrolIBA 01/2022
1	tofacitinibIBA 01/2022
1	Etanercept (Enbrel)FDA Link 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	dimethyl trisulfideIBA 03/2021
1	IodidesIBA 01/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2020
1	GYY 4137IBA 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	Sulfides (Thioethers)IBA 01/2019
1	Type A Botulinum Toxins (Botox)FDA Link 01/2019
1	Proteoglycans (Proteoglycan)IBA 12/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Amine Oxidase (Copper-Containing)IBA 01/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018
1	VildagliptinIBA 01/2018
1	AgglutininsIBA 12/2017
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2017
1	Substance PIBA 01/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017
1	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 06/2016

Therapy/Procedure

6	Ligation 03/2021 - 09/2003
4	Therapeutics 12/2023 - 10/2014
2	Drug Therapy (Chemotherapy) 03/2021 - 01/2017
2	Lasers (Laser) 12/2017 - 01/2016
1	Aftercare (After-Treatment) 01/2022
1	Injections 01/2018